Prognostic Impact of Lymphoid Enhancer Factor 1 Expression and Serum Galectin.3 in Egyptian AML Patients

BACKGROUND: Deregulation of the Wnt signaling pathway had a role in haematological malignancies. Previous studies reported that lymphoid enhancer factor 1 (LEF1) expression and serum Galectin-3 level could affect clinical parameters and outcome in acute myeloid leukemia patients, but as far as we kn...

Descripción completa

Detalles Bibliográficos
Autores principales: ElBaiomy, M. A., Aref, S., El Zaafarany, M., Atwa, Sara, Akl, Tamer, El-Beshbishi, Wafaa, El-Ashwah, Shaimaa, Ibrahim, L., El-Ghonemy, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6935809/
https://www.ncbi.nlm.nih.gov/pubmed/31929803
http://dx.doi.org/10.1155/2019/2352919

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6935809/
https://www.ncbi.nlm.nih.gov/pubmed/31929803
http://dx.doi.org/10.1155/2019/2352919

Ejemplares similares